These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28153611)

  • 41. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
    Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
    Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
    Asai K; Funaba M; Murakami M
    Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Micromolar sodium fluoride mediates anti-osteoclastogenesis in Porphyromonas gingivalis-induced alveolar bone loss.
    Bhawal UK; Lee HJ; Arikawa K; Shimosaka M; Suzuki M; Toyama T; Sato T; Kawamata R; Taguchi C; Hamada N; Nasu I; Arakawa H; Shibutani K
    Int J Oral Sci; 2015 Dec; 7(4):242-9. PubMed ID: 26674426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastrin-Releasing Peptide (GRP) Stimulates Osteoclastogenesis in Periodontitis.
    Choi Y; Heo SC; Kim YN; Joo JY; Hwang JJ; Bae MK; Kim HJ
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan.
    Hotokezaka H; Sakai E; Ohara N; Hotokezaka Y; Gonzales C; Matsuo K; Fujimura Y; Yoshida N; Nakayama K
    J Cell Biochem; 2007 May; 101(1):122-34. PubMed ID: 17171644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved RANKL expression and osteoclastogenesis induction of CD27+CD38- memory B cells: A link between B cells and alveolar bone damage in periodontitis.
    Han Y; Jin Y; Miao Y; Shi T; Lin X
    J Periodontal Res; 2019 Feb; 54(1):73-80. PubMed ID: 30346027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
    Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
    J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
    Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
    Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2.
    Wang YH; Nemati R; Anstadt E; Liu Y; Son Y; Zhu Q; Yao X; Clark RB; Rowe DW; Nichols FC
    Bone; 2015 Dec; 81():654-661. PubMed ID: 26409254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. E-cadherin is important for cell differentiation during osteoclastogenesis.
    Fiorino C; Harrison RE
    Bone; 2016 May; 86():106-18. PubMed ID: 26959175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inorganic phosphate-induced impairment of osteoclast cell-cell fusion by the inhibition of AP-1-mediated DC-STAMP expression.
    Arioka M; Takahashi-Yanaga F; Tatsumoto N; Sasaguri T
    Biochem Biophys Res Commun; 2017 Nov; 493(1):9-13. PubMed ID: 28939042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on the expression of EphA2 in osteoblasts and osteoclasts.
    Gao A; Wang X; Yu H; Li N; Hou Y; Yu W
    In Vitro Cell Dev Biol Anim; 2016 Feb; 52(2):228-34. PubMed ID: 26559065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
    Choo YY; Tran PT; Min BS; Kim O; Nguyen HD; Kwon SH; Lee JH
    Int Immunopharmacol; 2017 Nov; 52():230-237. PubMed ID: 28946117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
    Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
    J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).
    Kim K; Lee SH; Ha Kim J; Choi Y; Kim N
    Mol Endocrinol; 2008 Jan; 22(1):176-85. PubMed ID: 17885208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RANKL-induced DC-STAMP is essential for osteoclastogenesis.
    Kukita T; Wada N; Kukita A; Kakimoto T; Sandra F; Toh K; Nagata K; Iijima T; Horiuchi M; Matsusaki H; Hieshima K; Yoshie O; Nomiyama H
    J Exp Med; 2004 Oct; 200(7):941-6. PubMed ID: 15452179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The antimicrobial peptide, human β-defensin-1, potentiates in vitro osteoclastogenesis via activation of the p44/42 mitogen-activated protein kinases.
    Makeudom A; Supanchart C; Montreekachon P; Khongkhunthian S; Sastraruji T; Krisanaprakornkit J; Krisanaprakornkit S
    Peptides; 2017 Sep; 95():33-39. PubMed ID: 28709835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
    Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
    Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.